QINGDAO, China, Feb. 3, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of "Traditional Chinese Medicine (TCM) practice + modern medical technology", certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within parti ...

转自：贵州日报 本报讯 贵州省基层医疗机构分布零散，基层群众面临着"看病难、看病贵、看病远"等困难，贵州省卫 生健康委积极探索医疗卫生资源下沉的有效路径，在全国率先启动建设县域医疗次中心，2022—2025 年，每年规划建设50个共200个县域医疗次中心。 截至2025年，我省200个县域医疗次中心已全部建设完成，通过次中心建设，增加了卫生技术人员3769 名，增设业务科室2269个，已建成的次中心与建设前相比，县域内医疗服务能力得到明显改善，群众 在"家门口"就能享受到优质的医疗卫生服务。 （廉筠 吴碧霞 贵阳日报融媒体记者 张梅） （《设立200个医疗次中心 让群众看病更方便》由贵阳日报为您提供，转载请注明来源，未经书面授权 许可，不得转载或镜像。） 据介绍，我省创新构建了"县级公立医院—县域医疗次中心（中心乡镇卫生院）—一般卫生院—村卫生 室"梯次带动的紧密型县域医共体模式。由县域医共体牵头医院为龙头，有效整合院内医疗资源，通 过"人才、技术、管理、病种""四下沉"的方式，将次中心逐步打造成为所在片区医疗救治中心、急诊急 救中心、人才培训中心、技术指导中心、公共卫生示范中心。建成后的次中心向上分担县级医 ...

Core Viewpoint - Investors in Elevance Health, Inc. should closely monitor stock movements due to significant implied volatility in the options market, particularly the Mar 20, 2026 $460 Put option [1] Company Analysis - Elevance Health currently holds a Zacks Rank of 4 (Sell) within the Medical Services industry, which is positioned in the bottom 26% of the Zacks Industry Rank [3] - Over the past 60 days, no analysts have raised their earnings estimates for the current quarter, while seven analysts have lowered their estimates, resulting in a decrease of the Zacks Consensus Estimate from $10.79 per share to $10.35 [3] Options Market Insights - The high implied volatility surrounding Elevance Health shares suggests that options traders anticipate a significant price movement, indicating potential trading opportunities [4] - Seasoned options traders often seek high implied volatility options to sell premium, aiming to benefit from the decay of options value if the underlying stock does not move as much as expected [4]

分组1 - Revvity (RVTY) reported quarterly earnings of $1.7 per share, exceeding the Zacks Consensus Estimate of $1.63 per share, and up from $1.42 per share a year ago, representing an earnings surprise of +4.29% [1] - The company posted revenues of $772.06 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.02%, and an increase from $729.37 million year-over-year [2] - Revvity has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has gained approximately 12.5% since the beginning of the year, compared to the S&P 500's gain of 1.4% [3] - The current consensus EPS estimate for the upcoming quarter is $1.11 on revenues of $679.95 million, and for the current fiscal year, it is $5.32 on revenues of $2.94 billion [7] - The Zacks Industry Rank indicates that the Medical Services sector is currently in the bottom 27% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Group 1: Company Overview - SBC Medical Group Holdings Incorporated operates a diverse portfolio of franchise businesses across various medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology [6] - The company is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives [6] - SBC Medical was listed on Nasdaq in September 2024 and was included in the Russell 3000 Index in June 2025, indicating its growing prominence in the U.S. equity market [6][7] Group 2: Strategic Alliances and Initiatives - The alliance between SBC Medical and Daibi Medical Aesthetics aims to enhance understanding of China's medical environment and customer needs while increasing inbound customer visits to Shonan Beauty Clinic in Japan [1] - Physicians affiliated with Nasukai will collaborate with Daibi Medical Aesthetics to share knowledge on medical safety, clinic operations, and consultation practices, promoting professional exchange in aesthetic medicine between Japan and China [1] - Shonan Beauty Clinic has improved its inbound medical infrastructure, including the development of Chinese-language translation tools and the renewal of its official websites, to better serve overseas customers [3][4] Group 3: Market Trends and Growth Potential - The global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032, reaching approximately USD 62.18 billion by 2032, reflecting increasing global interest in medical tourism [2] - Japanese aesthetic medicine is gaining recognition across Asia for its advanced technologies and safety standards, contributing to a steady increase in inbound customer visits to Shonan Beauty Clinic, which nearly tripled from approximately 600 customers in early 2024 to around 1,700 by the end of 2025 [3]

Group 1 - The core event was a tea gathering titled "Riding Together for Spring Festival," organized by the Shenyang Beixin District Committee and the Xinchengzi Street, aimed at fostering communication among various community stakeholders, including new employment groups and state-owned enterprises [1] - The tea gathering served as a platform for "two new" organizations to connect government, enterprises, and new employment groups, emphasizing the importance of community governance and support for new workers [2] - The event highlighted social responsibility, with the Shenyang Charity Association and Daomeng Rice Industry providing "micro-wish gift packages" to delivery workers, showcasing the community's care and traditional cultural values [3] Group 2 - The "Rider's Council" was a significant part of the tea gathering, allowing new employment group representatives to voice their opinions on community governance issues, leading to practical suggestions for local improvements [4] - Since 2025, the community committee has collected over 60 suggestions through the "Rider's Council," addressing various local issues such as road repairs and expanding partnerships with private enterprises [4] - In 2026, the Shenyang Beixin District plans to hold eight series of activities for new employment groups during the Spring Festival, aiming to enhance community governance through direct engagement and support [4]

所谓的伽玛刀，并不是一把刀，而是一种无需开刀、用肉眼看不到的伽玛射线杀死肿瘤细胞的治疗技 术。它最大的优势是精准锁定病灶、实施打击，并最大限度保护肿瘤周围正常组织。 头体一体伽玛刀的引进，填补了福建地区头体一体精准放疗领域的技术空白。未来，该医院将依托该设 备开展多学科协作诊疗，为广大患者提供个性化治疗方案，持续提升区域肿瘤治疗水平的同时，让患者 无需远行即可得到国际前沿的精准放疗服务。 东南网2月1日讯（本网记者 冯川叶）无需开刀、听着音乐就能"躺赢"肿瘤，定位偏差小于0.5毫米，良 性恶性、头部体部肿瘤都能搞定，高龄、体弱患者安心治疗。近日，全省首台影像引导伽玛射线立体定 向放射治疗系统（即"头体一体伽玛刀"），正式落户国家区域医疗中心复旦大学附属华山医院、福建医 科大学附属第一医院（滨海院区）（简称"华山附一医院"）放疗科。这一肿瘤治疗的"硬核"设备，能实 现头颈部与体部肿瘤的一体化精准治疗，将随着华山附一医院放疗科开科同步投入使用。 ...

（来源：天津日报） 转自：天津日报 本报讯（记者 韩雯）在昨日市政府新闻办召开的新闻发布会上，市卫生健康委党委委员、副主任韩金 艳表示，今年民心工程将"老年髋部骨折救治暨跌倒骨折防治一体化工程"纳入重点任务，以"黄金48小 时"手术为核心，构建全链条保障体系，同时推进两家三甲医院新院区建设、提升托育服务水平，全方 位回应群众看病就医与育儿需求。 针对群众关切的托育痛点，市卫生健康委从人员培训与知识普及两方面发力提质增效。从业人员培训方 面，围绕法律法规、卫生保健、安全防护、应急处理等核心内容，采用线上线下相结合的方式开展培 训，计划线上参训不少于5000人次，线下实训不少于500人次；科学育儿宣传方面，组织托育机构开展 不少于160场次家长课堂、亲子活动，邀请专业人员通过媒体平台科普养育知识，举办16场托育主题宣 传活动，并利用商圈大屏、地铁线路等渠道扩大政策知晓度，切实减轻家庭生育教育负担。 天津医院党委书记徐卫国介绍，作为牵头医疗机构，天津市老年髋部骨折中心建设已开展一年，取得了 良好成效，把过去"复杂、漫长、充满不确定性的就医过程"，转变为对天津老年患者而言"快速、协 同、全程有保障的健康守护"。让不慎 ...

本报讯（记者孙乐琪）今天，本市启动互联网诊疗首诊服务试点。首批试点在北京儿童医院和首都儿童 医学中心的3个儿科亚专业开展，可为首诊患者提供线上预问诊、线上诊疗、药品配送等服务。 市卫健委强化全过程管理：加强对试点医疗机构的监督检查，发现医疗机构存在违反相关法律法规及互 联网诊疗首诊试点管理要求的，将责令立即整改；建立试点医疗机构首诊服务质量监管评价机制、患者 权益保障机制、负性事件处置机制，明确线上首诊终止情况（条件），及时转线下就诊，确保诊疗安全 和风险可控，保障患者权益；开展互联网诊疗首诊服务质量监管和评价，定期通报评价情况，并根据评 价情况动态调整政策。 本次试点的两家医院根据以往复诊经验，基本沿用互联网复诊操作流程。患者可通过微信搜索"北京儿 童医院"小程序或"首都儿童医学中心"公众号，点击进入"互联网医院"板块，按照提示选择标有"首 诊"字样的号源或科室预约首诊号。今天下午开放预约，患者最快可在明天进行线上首诊。目前，试点 医院可以为患者提供线上预问诊、线上诊疗、药品配送等服务，并将根据患者需求及时丰富完善服务内 容。 市卫健委相关负责人介绍，本市优质医疗资源集中，外地患者来京就医需求大，部分三级医 ...

Company Performance - Medpace's stock closed at $582.48, reflecting a decrease of -1.79% from the previous day, underperforming compared to the S&P 500's daily loss of 0.43% [1] - Over the last month, Medpace's shares have increased by 5.59%, outperforming the Medical sector's loss of 2.36% and the S&P 500's gain of 0.89% [1] Upcoming Earnings - Medpace is set to disclose its earnings on February 9, 2026, with analysts expecting earnings of $4.18 per share, indicating a year-over-year growth of 13.9% [2] - The consensus estimate for revenue is projected at $681.17 million, representing a growth of 26.94% compared to the same quarter last year [2] Full Year Projections - For the full year, Zacks Consensus Estimates project earnings of $14.8 per share and revenue of $2.5 billion, reflecting changes of +17.18% and 0% respectively from the prior year [3] - Recent changes to analyst estimates indicate a positive outlook for Medpace, as upward revisions are often seen as a sign of optimism regarding business trends [3] Valuation Metrics - Medpace has a Forward P/E ratio of 35.67, which is a premium compared to the industry average Forward P/E of 15.73 [6] - The company has a PEG ratio of 1.99, compared to the Medical Services industry's average PEG ratio of 1.77 [6] Industry Context - The Medical Services industry, which includes Medpace, ranks 178 in the Zacks Industry Rank, placing it in the bottom 28% of over 250 industries [7] - The Zacks Industry Rank evaluates the performance potential of industry groups, indicating that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]